Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|August 15, 2017

EFGCP Steps Up Search for COO

Author(s)Philip Ward

Applications for the vacant Brussels-based post of chief operating officer at the European Forum for GCP (EFGCP) are due to close on Friday August 18. EFGCP says it has earmarked a proposed start date of September 18 for the successful candidate.

The role will involve the following responsibilities:

  • ŸManagement of events, including conferences and workshops for between 40 and 150 participants and training courses.

  • ŸFinding venues for events, negotiating contracts, handling logistics, managing speakers and delegates, and overseeing marketing and promotions.

  • ŸProject management, including administrative and financial management of EFGCP participation in EU-funded projects and preparation of financial audits.

  • ŸCoordination of internal meetings, managing the website and IT, public representation, office management, and accounting, VAT, and legal issues.

  • ŸHuman resources (management of payroll and three-person staff).

According to the EFGCP, “The applicant should have strong self-motivation, interpersonal skills, be multi-tasks-oriented, possibly have experience in the healthcare sector and be able to work in a small team environment.”

It lists the job requirements as: experience in a coordination position and event organization; excellent written and oral communication skills in English (French is an asset); knowledge of financial management and bookkeeping and legal rules for associations based in Belgium; very well organized and caring for details; flexible, positive, and service-minded; excellent time management and respect of deadlines; and creative and resourceful problem-solving abilities.

Applications should include a CV in English and a one-page covering letter in English and be sent to jobs@efgcp.eu

Philip Ward is the European Editor for Applied Clinical Trials.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.